AU2003201559A1 - Multispecific binding molecules - Google Patents
Multispecific binding moleculesInfo
- Publication number
- AU2003201559A1 AU2003201559A1 AU2003201559A AU2003201559A AU2003201559A1 AU 2003201559 A1 AU2003201559 A1 AU 2003201559A1 AU 2003201559 A AU2003201559 A AU 2003201559A AU 2003201559 A AU2003201559 A AU 2003201559A AU 2003201559 A1 AU2003201559 A1 AU 2003201559A1
- Authority
- AU
- Australia
- Prior art keywords
- binding molecules
- multispecific binding
- multispecific
- molecules
- binding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/626—Diabody or triabody
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2368708 | 2002-01-14 | ||
CA2,368,708 | 2002-01-14 | ||
PCT/CA2002/000317 WO2002072141A2 (fr) | 2001-03-09 | 2002-03-11 | Ligands cibles |
AU2002240751 | 2002-03-11 | ||
CA 2397169 CA2397169A1 (fr) | 2002-08-13 | 2002-08-13 | Ligands cibles |
CA2,397,169 | 2002-08-13 | ||
CA2,402,930 | 2002-09-19 | ||
CA 2402930 CA2402930A1 (fr) | 2002-09-19 | 2002-09-19 | Ligands cibles |
PCT/CA2003/000044 WO2003057732A2 (fr) | 2002-01-14 | 2003-01-14 | Ligands cibles |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003201559A1 true AU2003201559A1 (en) | 2003-07-24 |
AU2003201559A8 AU2003201559A8 (en) | 2003-07-24 |
Family
ID=27426779
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003201559A Abandoned AU2003201559A1 (en) | 2002-01-14 | 2003-01-14 | Multispecific binding molecules |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1497331A2 (fr) |
AU (1) | AU2003201559A1 (fr) |
CA (1) | CA2513287A1 (fr) |
WO (1) | WO2003057732A2 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103172747A (zh) | 2005-01-25 | 2013-06-26 | 细胞治疗学公司 | 体内半衰期改变的生物活性蛋白质偶联物 |
WO2018224550A1 (fr) * | 2017-06-07 | 2018-12-13 | Philogen S.P.A | Protéines de fusion d'anticorps anti-facteur de croissance endothéliale vasculaire/anti-fibronectine |
WO2022036495A1 (fr) | 2020-08-17 | 2022-02-24 | Utc Therapeutics Inc. | Co-stimulateurs de cellules présentatrices d'antigène de lymphocytes et leurs utilisations |
AU2021329378A1 (en) | 2020-08-19 | 2023-03-23 | Xencor, Inc. | Anti-CD28 compositions |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2062795A1 (fr) * | 1989-06-29 | 1990-12-30 | Michael W. Fanger | Reactifs bispecifiques pour le traitement du sida |
AU658374B2 (en) * | 1990-09-14 | 1995-04-13 | Biosite Diagnostics Incorporated | Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays |
ES2191827T3 (es) * | 1996-10-17 | 2003-09-16 | Immunomedics Inc | Conjugado de toxina no antigenica y proteina de fusion de un sistema receptor de penetracion intracelular. |
EP1045861B1 (fr) * | 1998-01-15 | 2009-03-04 | Center For Molecular Medicine And Immunology | Substance de ciblage bispecifique comprenant (i) un anticorps contre le cea (carcinoembryonic antigen) et (ii) la region de la sous-unité alpha du recepteur de l'il13 responsable de la liaison avec le ligand. |
WO2000018806A1 (fr) * | 1998-09-25 | 2000-04-06 | Horst Lindhofer | Anticorps bispecifiques et trispecifiques reagissant de façon specifique avec des antigenes d'enveloppe pouvant etre induits, en tant que structures cibles operationnelles |
AU7524601A (en) * | 2000-06-05 | 2001-12-17 | Sunol Molecular Corp | T cell receptor fusions and conjugates and methods of use thereof |
EP1455820A2 (fr) * | 2001-03-09 | 2004-09-15 | William Herman | Ligands cibles |
-
2003
- 2003-01-14 WO PCT/CA2003/000044 patent/WO2003057732A2/fr not_active Application Discontinuation
- 2003-01-14 CA CA002513287A patent/CA2513287A1/fr not_active Abandoned
- 2003-01-14 AU AU2003201559A patent/AU2003201559A1/en not_active Abandoned
- 2003-01-14 EP EP03700256A patent/EP1497331A2/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1497331A2 (fr) | 2005-01-19 |
CA2513287A1 (fr) | 2003-07-17 |
WO2003057732A2 (fr) | 2003-07-17 |
WO2003057732A3 (fr) | 2003-10-02 |
AU2003201559A8 (en) | 2003-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003303586A1 (en) | Methods for attaching molecules | |
AU2003288304A1 (en) | Novel molecules derived from noraporphine | |
EP1585970A3 (fr) | Procedes destines a separer des molecules | |
AU2003272930A1 (en) | Footwere | |
AU2003904230A0 (en) | Snowboard binding | |
EP1572168A3 (fr) | Molecules anti-infarcissement | |
AU2002951388A0 (en) | Bookmark | |
IL166361A0 (en) | Binding molecules | |
AU2003274573A1 (en) | Deburrer | |
AU2003201559A1 (en) | Multispecific binding molecules | |
AU2003236612A1 (en) | Secretory molecules | |
AU2003212825A1 (en) | Aggrecanase molecules | |
AU2003904181A0 (en) | Clamp | |
AU2003243143A1 (en) | 2-methyl-thieno-benzodiazepine process | |
AU2003275529A1 (en) | Binding strap rack | |
AU2003230760A1 (en) | Lipid-associated molecules | |
AU2003276655A1 (en) | Pi - conjugated molecules | |
AU2003903723A0 (en) | Process | |
AU2003241210A1 (en) | Videocomputer | |
GB0219013D0 (en) | Modified integration binding molecules | |
GB0327532D0 (en) | Specific binding molecules | |
AU2003901533A0 (en) | Bookmark | |
AU2003900307A0 (en) | Novel binding domain | |
AU2003906979A0 (en) | Novel binding domain | |
AU2003904694A0 (en) | Purifying molecules |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |